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Abstract
An intramolecular dehydrogenative C–H activation enabled an efficient synthesis of an uracil-annulated β-carbolinone ring system.
The reaction is simple, efficient and high yielding (85–92%).
Introduction
The presence of a β-carbolinone skeleton in various natural
products, such as secofascaplysin A (I), SL651498 (II)
(Figure 1), and their remarkable biological and pharmacolog-
ical properties make them stand out amongst all the carboline
class of compounds [1-12]. For example, SL651498 was docu-
mented as a potential drug development candidate in a research
program designed to discover subtype-selective GABAA
receptor agonists for the treatment of muscle spasms and gener-
alized anxiety disorder [13]. β-Carbolinones such as strychno-
carpine, the alkaloid from Alstonia venenata, and substituted
1-oxo-13-carbolines were also shown to have serotonin-
receptor-binding activity (5-HT receptor) [14]. Moreover the
natural and synthetic β-carbolines are also known to show anti-
cancer activity against colon and lung cancers, and some
β-carbolinones act as biological control agents for receptor Figure 1: Naturally occurring β-carbolinones.
research on bioenzyme inhibitors, such as the inhibition of HLE
(human leukocyte elastase) [15-18].
Uracil, on the other hand, is one of the four nucleobases of
RNA. It holds immense importance from a pharmaceutical and
Beilstein J. Org. Chem. 2015, 11, 1360–1366.
1361
Scheme 1: Preparation of starting substrate.
biological point of view [19]. For example, 5-fluorouracil [20]
and other uracil-based molecules [21-23] such as 3’-azido-3’-
deoxythymidine (AZT), 2’,3’-dideoxycytidine (DDC), (E)-5-[2-
(bromovinyl)-2’-deoxyuridine] (BVDU), are active against
cancer and the HI virus [24-31].
Diverse approaches towards the synthesis of β-carbolinones
have been developed [32-36], such as an intramolecular Heck
reaction strategy of 2- and 3-iodoindoles for the synthesis of β-
or γ-carbolinones by Beccalli et al. [32], AuCl3 and
Pd-catalyzed cycloisomerization of indole-2-carboxamides to
β-carbolinones [33-35], Pd-catalyzed dehydrogenative annula-
tion of indole-carboxamides with alkynes etc [36]. The develop-
ment of metal-catalyzed C–H activation reaction has revolution-
ized the way a synthetic chemist now approaches a traditional
C–C bond disconnection [32-44]. Dehydrogenative C–H acti-
vation [45-52] is the most elegant alternative in this endeavor as
it avoids pre-functionalization of any C–H bond beforehand.
But regioselectivity is the main problem in this type of reaction
due to the ubiquitous presence of various C–H bonds in a
simple organic molecule. However, sometimes the issue of
regioselectivity can be resolved by the electronic property of the
substrate itself. Pioneering work published by Fagnou et al.
shows how a catalyst inverts its selectivity and reactivity
between the coupling partners to achieve indole C3-arylation in
a cross coupling reaction of an unactivated arene and
N-acetylindole [53]. Driven by the same logic and guided by
our previous work we envisioned that an intramolecular dehy-
drogenative cross coupling reaction could be achievable
between the electron deficient uracil C6–H bond adjacent to the
nitogen atom and the electron rich indole C3–H bond for the
synthesis of uracil annulated β-carbolinones [54-56]. Herein, we
report our novel approach towards the synthesis of uracil annu-
lated β-carbolinones via an intramolecular dehydrogenative
coupling reaction of indole-2-carboxamides.
Results and Discussion
We started our investigation with the preparation of amide
precursors 4 from N-substituted indole-2-carboxylic acids 1
(Scheme 1). The acids were treated with oxalyl chloride at room
temperature [33] and the resulting acid chloride obtained was
transformed to the amide by the reaction with amine 3 in dry
THF using NaH as a base.
The amide precursor was then subjected to a series of reactions
in pursuit of the best reaction conditions for the dehydrogena-
tive cross-coupling process. Assuming that the reaction goes
through an electrophilic metallation pathway, it was projected
that Pd(OAc)2 would be an excellent starting point for catalyst
screening. The amide 4a (R1 = R2 = R3 = R4 = Me) was used as
a model substrate for this dehydrogenative coupling reaction.
The reaction was set up in the presence of Pd(OAc)2
(10 mol %), Cu(OAc)2 (2 equiv) in DMF under open air at
70 °C (Table 1, entry 1). After 8 h we obtained 35% yield of 5a
with 52% conversion of starting material. Increasing the
temperature to 90 °C (Table 1, entry 2) afforded 63% yield of
5a with 80% conversion of 4a. Then different oxidants
[Cu(OTf)2, PhI(OAc)2, K2S2O8, (NH4)2S2O8, p-benzoquinone
(BQ), oxone, AgOAc, molecular oxygen] were examined under
these reaction conditions. With Cu(OTf)2 (Table 1, entry 3) and
oxone (Table 1, entry 8), total recovery of starting material was
observed while PhI(OAc)2 (Table 1, entry 4), (NH4)2S2O8
(Table 1, entry 6) showed total decomposition of starting ma-
terial. With BQ the yield was almost the same (65%) as with
Cu(OAc)2 (Table 1, entry 7). The use of K2S2O8 increased the
yield of 5a to 83% (Table 1, entry 5) with complete conversion
of starting material; AgOAc further increased the yield to 91%
(Table 1, entry 9). Molecular oxygen also used as an oxidant
resulted in a low 30% yield of 5a (Table 1, entry 10) with 51%
conversion of 4a. Examination of different solvents led to deter-
mining that the polar solvents (DMF/DMSO (9:1), DMSO,
DMAc, Table 1, entries 11, 12, 13) were far superior compared
to non-polar solvent toluene (Table 1, entry 14). But the optimal
result was obtained with the use of DMF (Table 1, entry 9).
Testing the efficiency of other Pd catalysts for this reaction
revealed that Pd2dba3, i.e., Pd(0) did not show any catalytic
activity (Table 1, entry 17). The yield decreased sharply for
other Pd catalysts such as PdCl2, Pd(CH3CN)2Cl2 and
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Table 1: Optimization of intramolecular dehydrogenative coupling.
Entry Catalyst Oxidant Solvent Temp (°C) Conversion (%)a Yield (%)b
1 Pd(OAc)2 Cu(OAc)2 DMF 70 52 35
2 Pd(OAc)2 Cu(OAc)2 DMF 90 80 63
3 Pd(OAc)2 Cu(OTf)2 DMF 90 0 0
4 Pd(OAc)2 PhI(OAc)2 DMF 90 0 0
5 Pd(OAc)2 K2S2O8 DMF 90 100 83
6 Pd(OAc)2 (NH4)2S2O8 DMF 90 0 0
7 Pd(OAc)2 BQ DMF 90 78 65
8 Pd(OAc)2 oxone DMF 90 0 0
9 Pd(OAc)2 AgOAc DMF 90 100 91
10 Pd(OAc)2 O2 DMF 90 51 30
11 Pd(OAc)2 AgOAc DMF/DMSO (9:1) 90 100 82
12 Pd(OAc)2 AgOAc DMSO 90 100 78
13 Pd(OAc)2 AgOAc DMAc 90 100 80
14 Pd(OAc)2 AgOAc toluene 90 40 30
15 PdCl2 AgOAc DMF 90 83 52
16 Pd(CH3CN)2Cl2 AgOAc DMF 90 70 35
17 Pd2(dba)3 AgOAc DMF 90 0 0
18 Pd(PPh3)2Cl2 AgOAc DMF 90 40 32
All reactions were performed with 1 equiv starting material (4), 10 mol % Pd-catalyst, 2 equiv oxidant in 5 mL solvent at mentioned tempetature, 8 h
under open air. aCalculation on the basis of isolation of starting material. bIsolated yield.
Pd(PPh3)2Cl2 presumably be due to the less electrophilic nature
of these catalysts (Table 1, entries 15, 16, 18).
With the optimized reaction conditions in hand (10 mol %
Pd(OAc)2, 2 equiv AgOAc in DMF at 90 °C for 8 h), we further
explored the substrate scope of the reaction (Scheme 2).
All the reactions went very smoothly giving excellent yields in
the range of (85–92%). No distinct steric influence was noticed
when the indole-N-methyl group was replaced by ethyl, butyl or
benzyl groups. However, the reaction did not proceed at all with
the unsubstituted indole precursor (R1 = H, 4m), this result may
be explained with potential coordination of the Pd catalyst
between the indole nitrogen and amide carbonyl oxygen. A
representative X-ray crystal structure of β-carbolinone deriva-
tive 5h was obtained [57] (Figure 2).
The inactivity of Pd(0) (Table 1, entry 17), and inferior reactiv-
ity of other less electrophilic Pd catalysts indicates a mecha-
nistic pathway that commence with electrophilic metalation at
Figure 2: ORTEP diagram of 5h.
the indole C3 postion. The nucleophilicity of indole at C3 is
well known [58] and a similar kind of electrophilic reaction
leads to the intermediate A (Scheme 3). We believe this inter-
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Scheme 2: Synthesis of various β-carbolinone derivatives.
mediate then undergoes a σ-bond metathesis reaction to form a
seven membered palladacycle B which in turn produces the
product β-carbolinones after reductive elimination from the
7-membered palladacycle B. The catalytic cycle is completed
by AgOAc.
Conclusion
In conclusion we have developed an elegant method for the
preparation of uracil annulated β-carbolinones via a high
yielding dehydrogenative C–H activation process. The
key to the success of this reaction is the complementary elec-
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Scheme 3: Proposed mechanistic pathway.
tronic properties of the indole C3–H bond and the uracil C6–H
bond. It is anticipated this efficient and atom economic ap-
proach can be emulated for the preparation of other β-carboli-
nones as well, and further results in this regard will be reported
in due course.
Experimental
Representative procedure for the preparation of uracil annu-
lated β-carbolinones (5a–m):
In a flame-dried round bottomed flask equipped with a
magnetic bar, a mixture of 1 equiv starting material 4, 5 mL
dry DMF, 2 equiv of AgOAc and 10 mol % Pd(OAc)2 was
taken and stirred at room temperature for 5 min. Then the reac-
tion mixture was heated in an oil bath fixed at 90 °C for 8 h
under air. Completion of the reaction was monitored by
checking TLC. The reaction mixture was cooled to room
temperature, diluted with water and 50 mL of EtOAc and
passed through a pad of celite. The organic layer was washed
with H2O (2 × 10 mL) and saturated NaCl (aq) (1 × 10 mL).
The organic part was dried over Na2SO4, evaporated and puri-
fied by flash chromatography, using ethyl acetate/petroleum
ether (2:8) as the eluent to afford product 5. For details see
Supporting Information File 1.
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